• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    A Clearer Path to Weight Management: The Ozempic Factor

    Under Pressure: Stress and Mental Health Have Taken Center Stage

    Sustainable Business Development: Principles and Strategies for Progress

    Beauty IO MarketWatch: L’Oréal to Define the Next Era of Beauty Tech in CES 2024 Keynote

    Introducing the Happi & Nutraceuticals World Wellness Conference & Tabletop Exhibition
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    ABC’s Journal HerbalGram Celebrates 40th Anniversary

    Curcumin May Be As Effective as PPI for Indigestion

    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies

    Women in Nutraceuticals Launches Pilot Mentorship Program

    What’s Up With Supps to Host SupplySide West Closing Party
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    ABC’s Journal HerbalGram Celebrates 40th Anniversary

    Curcumin May Be As Effective as PPI for Indigestion

    Weight Loss Products Sold as Supplements Adulterated with Toxic Yellow Oleander

    Nature’s Way Canada Launches NutraSea Omega-3 Kids Chews

    Kyowa Hakko's Immuse Postbiotic Introduced to Mexican Market
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    ABC’s Journal HerbalGram Celebrates 40th Anniversary

    Curcumin May Be As Effective as PPI for Indigestion

    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies

    Women in Nutraceuticals Launches Pilot Mentorship Program

    Weight Loss Products Sold as Supplements Adulterated with Toxic Yellow Oleander
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Curcumin May Be As Effective as PPI for Indigestion

    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies

    Weight Loss Products Sold as Supplements Adulterated with Toxic Yellow Oleander

    Nature’s Way Canada Launches NutraSea Omega-3 Kids Chews

    Kyowa Hakko's Immuse Postbiotic Introduced to Mexican Market
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Xsto Solutions

    KLK OLEO

    BGG World

    American FlexPack
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Xsto Solutions

    KLK OLEO

    BGG World

    American FlexPack
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision

    Increasingly, FDA has used this ‘race to market’ language of DSHEA to prevent or remove safe and legitimate dietary ingredients from commerce.

    Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision
    By James J. Gormley, Gormley NPI Consulting03.16.23
    Today, 46% of the budget of the U.S. Food and Drug Administration (FDA) comes from user fees that pharmaceutical and biotech companies pay when they apply for approval of a drug or medical device.

    Unfortunately, according to attorney Jonathan Emord: “As FDA medical reviewers have repeatedly stated in congressional testimony, FDA views the drug industry as its ‘client’ and does its client’s bidding.”

    So it is, perhaps, not completely surprising that the FDA has in superficie demonstrated, particularly in the years since the enactment of the Dietary Supplement Health and Education Act of 1994 (DSHEA), that it will do almost anything in its powers, and often outside of those powers, to favor pharmaceutical products, often at the expense of safe dietary supplement ingredients.

    In recent years, the FDA has made liberal use of the exclusion clause, which states that a product cannot be marketed as a dietary supplement if it includes an “article” that has been: 1) approved as a new drug, or 2) authorized for investigation as a new drug a) for which substantial clinical investigations have been instituted on the article and their existence made public, and b) was not marketed as a food or dietary supplement prior to being authorized for investigation as a new drug.

    Cholestin, pyridoxamine, vinpocetine, CBD, NAC, and NMN are examples of this provision (and other safety provisions) being invoked, or misused, with the latter four ingredients today in various levels of regulatory limbo.

    Red Yeast Rice and Pyridoxamine

    Pharmanex v. Shalala was a 2001 case in which the U.S. Court of Appeals ruled that the FDA had the authority to prohibit a company, Pharmanex, from marketing its Cholestin red yeast rice as a supplement. Cholestin’s active compound—monacolin K—was identical to lovastatin which was approved as a cholesterol-lowering drug (Mevacor) in 1987.

    Red yeast rice—a rice fermented with the mold Monascus purpureus—is considered a traditional Asian food that has a long history of use in Chinese medicine to support digestion and healthy circulation. The FDA claimed that Pharmanex was intentionally manufacturing its product to contain high levels of the statin compound and was marketing it for its cholesterol-lowering benefits.

    Cholestin was excluded from the dietary supplement definition under the exclusion clause because the approval of Mevacor as a new drug preceded Pharmanex’s marketing of lovastatin as a dietary supplement.

    In 2009, FDA removed pyridoxamine (a form of vitamin B6) from the market when it invoked the exclusion provision and claimed there was no evidence the article was marketed as a supplement prior to the initiation of clinical trials for the ingredient as a drug. 

    CBD, Vinpocetine and NAC: A Hazy Regulatory Landscape

    The 2018 Farm Bill removed hemp with no more than 0.3% THC content on a dry weight basis from the Controlled Substances Act (CSA). FDA quickly invoked 201(ff)(3)(B) of the Federal Food, Drug and Cosmetic Act (FD&C Act) to claim that CBD is precluded from being a dietary ingredient because of the prior approval of Epidiolex as a drug. This artificial hurdle has dogged mainstream retailers from selling ingestible CBD products for years now.

    CBD has been in a regulatory twilight zone ever since. In fact, in January 2023, the FDA threw up its hands, saying a new regulatory pathway for CBD is needed, which might be great, say some, if it is a carve out, but could also set a dangerous precedent.

    “When you read between the lines of today’s FDA statement, the agency appears to be saying that it would prefer to defy and attack DSHEA and develop different regulatory paths for ingredients at its own discretion,” said Daniel Fabricant, PhD, president and CEO of the Natural Products Association (NPA).

    “That could include requiring premarket approval, unnecessary testing, or who knows what. That is an especially dangerous precedent not only for CBD but for the entire natural products industry and ingredients like hemp that clearly fall under the agency’s jurisdiction.”

    On Jun. 3, 2019, FDA issued a safety warning for women of childbearing age about vinpocetine, a compound that is derived from vincamine, an alkaloid found in the Vinca minor L. plant.

    To date, vinpocetine is supported by 26 years of lawful historical safe use in the U.S. alone as a food and 45 years of safe use in Europe as a functional food.

    According to NPA, the FDA and the European Union consider 25 years of widespread use to be the minimum to establish a history of safe use, according to their definition. “As NPA is unaware of any chemical changes to vinpocetine over the past [45] years, this dietary ingredient has demonstrated sufficient historical safe use worldwide and domestically as a lawfully marketed dietary ingredient for use in dietary supplements,” NPA noted in 2016.

    In the summer of 2020, the FDA claimed that because N-acetyl cysteine (or NAC) was approved in 1963 as an inhaled drug (Mucomyst) for obstructive lung disease, and again in 1985 as an oral drug (Acetadote) to treat acetaminophen toxicity, it cannot be legally allowed in supplements. That’s despite the fact that NAC supplements have been safely marketed and consumed for more than 30 years.

    In making the case for excluding NAC as a supplement, the agency referenced a 60-year-old drug approval for an inhaled form of the compound that was discontinued many years ago.

    After leading the battle in securing final guidance for NAC through a citizen petition and lawsuit, NPA dismissed its lawsuit against the agency, which still “preserves legal rights and standing should additional action be necessary,” NPA said in a November 2022 press release. “The guidance also initiates the process for export certificates for NAC, which was a primary objective of the trade association’s strategy.”

    The FDA will, for now, exercise enforcement discretion for the ingredient, essentially agreeing to ignore the sale of NAC-containing supplements provided that those products are not making non-compliant claims.


    “This life-extending substance should be widely available, but the FDA is creating a situation in which only those who can afford to pay exorbitant drug prices will be able to enjoy NMN’s many benefits.”
    —Gretchen DuBeau, Alliance for Natural Health USA


    NMN in the Crosshairs

    This brings us to late 2022, when the FDA made a determination that β-NMN (beta-nicotinamide mononucleotide, or NMN) could not be sold in nutritional supplements by virtue of its investigation as a drug prior to its lawful marketing as a dietary supplement.

    Industry representatives broadly criticized FDA’s decision, noting the agency’s failure to raise the drug exclusion issue in its previous review of NMN ingredient notifications that are required under DSHEA.

    “FDA’s sudden and contradictory announcement relative to the regulatory status of NMN as a dietary ingredient that is excluded from the definition of a dietary supplement, along with the arbitrary, erroneous, unreasonable and inequitable interpretation of the Act it relied on, adversely affects the entire dietary supplement stakeholder community,” stated NPA and the Alliance for Natural Health in a joint citizen petition dated Mar. 7, 2023.

    “The current situation with NMN is yet another example of the inconsistent and mercurial way in which FDA chooses to both interpret DSHEA and use its limited resources to supposedly protect the public health. FDA has not articulated any risk to the safety of the public posed by NMN when marketed as a dietary ingredient or dietary supplement.”

    “NMN is found in foods like broccoli, avocado, and cucumbers,” said Gretchen DuBeau, executive and legal director of the Alliance for Natural Health USA, upon the filing of the joint citizen petition with NPA over NMN. “This life-extending substance should be widely available, but the FDA is creating a situation in which only those who can afford to pay exorbitant drug prices will be able to enjoy NMN’s many benefits.”

    It's Not About Safety

    It’s important to remember that safety is not the issue in these cases; it’s an economic argument to protect the financial incentives to carry out drug research. Does the statute envision that safety should even be a consideration? Law does not instruct FDA how to determine that the article “would be lawful under this chapter.”

    If “the article” was first marketed as a supplement after 1994, under a new dietary ingredient (NDI) notification, is it enough to show the ingredient is reasonably expected to be safe? Or that it is marketed for a different indication than its pharmaceutical analogue?

    Clearly, the exclusionary rule of DSHEA is increasingly being used to prevent or remove safe and legitimate dietary ingredients from the market, in some cases retroactively applied decades after a dietary ingredient was introduced and safely used by consumers.

    Will Woodlee, general counsel to the American Herbal Products Association (AHPA), said during the association’s Regulatory Congress last fall that the easiest fix would be to have Congress “clearly codify the concept that prior drug exclusion doesn’t apply to ingredients that were on the market before DSHEA was enacted. For now, the industry needs to constantly look over its shoulder at all of the information from every drug company so that they know what opportunities FDA will have to pull the rug out from under them again.”

    “Our system is broken,” added DuBeau. “The FDA is allowing pharmaceutical companies to ransack nature by monopolizing nutrients that can and should be dietary supplements.”

    A Way Out … or Forward

    Law does provide a way out of this quagmire, however. The drug exclusion provision states, “…unless the Secretary [of Health and Human Services], in the Secretary’s discretion, has issued a regulation, after notice and comment, finding that the article would be lawful under this chapter.”

    So the FDA has an opportunity to resolve these conflicts when they arise with rulemaking that grants an exception to the statutory race to market. So even if the “article” is the same for the drug and supplement—and there are many ways why they are not—FDA could fix the problem.

    Unfortunately, FDA has never exercised this authority and does not seem willing to do so now for either NAC or CBD. It would seem, say some, that the FDA would rather go on a fishing expedition through its archives to find some dusty clinical use application that has been long since abandoned.

    All this emphasizes the need for a reexamination of the exclusionary rule. FDA could issue guidance on this topic, but failing that, Congress needs to revise this section of the statute.

    This race to market should not support pharmaceutical interests at the cost of denying consumers access to effective supplements that can, and do, significantly enhance health.



    About the Author: James Gormley has been an award-winning natural products industry writer, editor and thought leader since 1995. The head of Gormley NPI Consulting, James can be reached via his website, JamesGormley.com or via email at jamesgormley01@gmail.com.
    Related Searches
    • Antioxidants
    • Vitamins
    • Dietary Supplements
    • Regulations
    Related Knowledge Center
    • Vitamins
    • Dietary Supplements
    • Regulations
    • Herbs & Botanicals
    • Antioxidants
    Suggested For You
    Constipation, Sleep, and Stress: Digexin® Does What Others Promise Constipation, Sleep, and Stress: Digexin® Does What Others Promise
    Weight Loss Products Sold as Supplements Adulterated with Toxic Yellow Oleander Weight Loss Products Sold as Supplements Adulterated with Toxic Yellow Oleander
    ODSP Director Highlights Agency Priorities Amid Proposed Reorganization ODSP Director Highlights Agency Priorities Amid Proposed Reorganization
    CHPA Petitions FTC to Withdraw Notice of Penalty Offenses Sent to Hundreds of Companies CHPA Petitions FTC to Withdraw Notice of Penalty Offenses Sent to Hundreds of Companies
    Nature’s Way Canada Launches NutraSea Omega-3 Kids Chews Nature’s Way Canada Launches NutraSea Omega-3 Kids Chews
    Kyowa Hakko Kyowa Hakko's Immuse Postbiotic Introduced to Mexican Market
    Probiotix Health Launches New Heart Health Supplement CholBiome Probiotix Health Launches New Heart Health Supplement CholBiome
    Fatty Acid Supplement Linked to Better Vision in Preterm Babies Fatty Acid Supplement Linked to Better Vision in Preterm Babies
    The Rise of Phytonutrients and Opportunities for Innovative Formulations The Rise of Phytonutrients and Opportunities for Innovative Formulations
    Nutrartis Launches Cardiosmile Plant Sterols in U.S. Nutrartis Launches Cardiosmile Plant Sterols in U.S.
    Ashwagandha/Okra Complex Linked to Digestive, Mood Benefits Ashwagandha/Okra Complex Linked to Digestive, Mood Benefits
    Nordic Naturals, Sam Nordic Naturals, Sam's Club Enter Exclusive Retail Partnership
    Postbiotic May Suppress Cold-Like Symptoms Postbiotic May Suppress Cold-Like Symptoms
    Eurofins Adopts California Poppy Through ABC’s Adopt-an-Herb Program Eurofins Adopts California Poppy Through ABC’s Adopt-an-Herb Program
    Designs for Health Appoints Amardeep Kahlon as CEO Designs for Health Appoints Amardeep Kahlon as CEO

    Related Webinars

    • Constipation, Sleep, and Stress: Digexin® Does What Others Promise

      Constipation, Sleep, and Stress: Digexin® Does What Others Promise

      Register for this FREE webinar
      09.22.23

    • Breaking News | Dietary Supplements | Herbs & Botanicals | Industry & Market News | Quality & Safety | Testing | Weight Management/Weight Loss
      Weight Loss Products Sold as Supplements Adulterated with Toxic Yellow Oleander

      Weight Loss Products Sold as Supplements Adulterated with Toxic Yellow Oleander

      Unrelated FDA and CDC research revealed the presence of this adulterant in product testing spurred by hospitalizations.
      Mike Montemarano, Associate Editor 09.19.23

    • Dietary Supplements | Quality & Safety | Regulations
      ODSP Director Highlights Agency Priorities Amid Proposed Reorganization

      ODSP Director Highlights Agency Priorities Amid Proposed Reorganization

      Dr. Cara Welch said the agency is eyeing many regulatory efficiencies.
      By Mike Montemarano, Associate Editor 09.18.23


    • Breaking News | Industry & Market News | Regulations | Regulatory News
      CHPA Petitions FTC to Withdraw Notice of Penalty Offenses Sent to Hundreds of Companies

      CHPA Petitions FTC to Withdraw Notice of Penalty Offenses Sent to Hundreds of Companies

      The trade organization said the notices issued earlier this year were inconsistent with regulatory practice, and unenforceable because they violate due process.
      09.18.23

    • Breaking News | Dietary Supplements | Infant & Children's Health | Omega-3s | Products
      Nature’s Way Canada Launches NutraSea Omega-3 Kids Chews

      Nature’s Way Canada Launches NutraSea Omega-3 Kids Chews

      The new gummy delivers 500 mg of EPA and DHA per serving, along with 500 IU vitamin D3.
      09.18.23

    Loading, Please Wait..
    Trending
    • Todd Spear Joins Protein Research As VP Of Sales And Marketing
    • Clinical Trial Shows Long-Term Joint Health Benefits Of PLT’s Boswellia Serrata Extract
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    • HMB And Vitamin D Supplementation Linked To Reduction In Fat Stores
    • Soviets Took Probiotics To The Next Level
    Breaking News
    • GOED Releases Sustainability Report for Omega-3s Industry
    • ABC’s Journal HerbalGram Celebrates 40th Anniversary
    • Curcumin May Be As Effective as PPI for Indigestion
    • Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies
    • Women in Nutraceuticals Launches Pilot Mentorship Program
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • A Clearer Path to Weight Management: The Ozempic Factor
    • Under Pressure: Stress and Mental Health Have Taken Center Stage
    • Sustainable Business Development: Principles and Strategies for Progress
    • BIOHM Health Targets ‘Digestive Plaque’ with Probiotic, Fungus, and Enzyme Formula
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    ABC’s Journal HerbalGram Celebrates 40th Anniversary
    Curcumin May Be As Effective as PPI for Indigestion
    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies
    Coatings World

    Latest Breaking News From Coatings World

    Nouryon Manufacturing Network Transitions to 100% Electricity From Renewable Sources in Brazil
    Jay Doubman Named President and CEO of ICP Group
    “MyCarbonFootprint”: BASF Launches Dashboard for Sustainable Procurement
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Clears MeMed BV Direct From Whole Blood
    Biostrap Debuts Tool to Measure Stress Resilience, Heart Rate Variability
    EndoTheia Announces Positive Study Results for Endoscopic Surgery Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Chime, Panolos Partner to Advance Multi-specific Therapeutic Proteins
    SocietalCDMO Announces Corporate Restructuring
    Altasciences Selected by Virpax to Support Flu Drug
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Hailey Bieber's Rhode Expands Into Makeup
    Avon Enters Retail Partnership with Superdrug
    IT Award Winners Announced at MakeUp in NY
    Happi

    Latest Breaking News From Happi

    Ideal Image Offers FDA-Approved Alternative to Botox
    Divi Expands in Stores at Ulta Beauty Tripling Footprint
    Huda Beauty Adds Easy Bake and Snatch Pressed Brightening and Setting Powder
    Ink World

    Latest Breaking News From Ink World

    INKBANK Lays Foundation for Science and Technology Park
    Successful Labelexpo Europe 2023 Concludes in Brussels
    Recyclable, Deinkable Stand-Up Pouch Wins Gold
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Flexo Wash to exhibit at FTA Fall Technical Conference
    Recyclable, deinkable stand-up pouch wins Gold in Germany
    Elkem highlights thermal protection and battery assembly products
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Completes Work On Extra Wide Carding, Blending Line
    Ahlstrom Launches Nonwoven Laundry Care Product
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Anika Releases RevoMotion Reverse Shoulder Arthroplasty System
    Exactech's Activit-E Polyethylene OK'ed for Vantage Total Ankle
    Tyber Nets Several Regulatory Nods for K-Wires, Steinmann Pins
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    HMI Specialist RAFI Acquires Xymox Technologies Inc.
    Infineon Heads EECONE European Research Project
    NXP Honored with Prestigious Automotive Awards

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login